{
  "report_rows": [
    {
      "kpi": "Operating EPS",
      "prediction": "MISS",
      "answer": "pred ~$2.40 vs. cons $2.46",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Consolidated Combined Ratio",
      "prediction": "MISS",
      "answer": "pred ~85.0% vs. cons 83.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Reinsurance Segment Net Premiums Written Growth (YoY)",
      "prediction": "MISS",
      "answer": "pred ~-9% vs. cons -5%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Insurance Segment Underwriting Expense Ratio",
      "prediction": "BETTER",
      "answer": "guide ~37.5% vs. cons 38.5% (H2 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Reinsurance Net Premiums Written Growth",
      "prediction": "LOWER",
      "answer": "guide ~-7% vs. cons -4% (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Full-Year Operating ROE",
      "prediction": "LOWER",
      "answer": "guide ~14% vs. cons 15% (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Reinsurance property-cat softening into 6/1-7/1 renewals plus continued Iran/political-violence loss emergence and elevated H1 SCS activity (CINF's cat miss as a read-through) point to downward FY26/27 estimate revisions on both top-line (reinsurance NPW) and combined ratio; negative Earnings ESP and pre-print downward revisions suggest sell-side cuts extend for several days post-print rather than reverse, especially since expense-ratio normalization and buyback support are already largely priced in after the stock's ~20% run into the print, leaving more room for disappointment to compound than for a snap-back.",
  "day5_confidence": "LOW"
}